Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA clears Pheromone's predictive fertility monitor

This article was originally published in Clinica

Executive Summary

Pheromone Sciences has gained US FDA clearance for its wristwatch-like PSC Fertility Monitor, which the firm claims provides more advanced notice of ovulation to women than any other marketed device. The company estimates that the North American market for fertility related products will increase gradually from its current level of around $450m, to some $560m by 2007.

Topics

UsernamePublicRestriction

Register

MT068358

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel